Skip to main content
. Author manuscript; available in PMC: 2012 Jan 17.
Published in final edited form as: Hypertension. 2003 Dec 22;43(2):229–236. doi: 10.1161/01.HYP.0000107777.91185.89

Effect of Ac-SDKP on Blood Pressure, Infarct Size, Left Ventricular Weight, Myocyte Size, and Cardiac Function

SBP (mm Hg) HR (bpm) IS (% LV) LVW/BW (mg/10 g) MCSA (μm2) LVDd (mm) EF (%) E/A
Sham MI 115.2±2.5 346±8 ... 17.0±0.2 205±4 5.9±0.1 59.6±3.1 1.64±0.06
MI–vehicle (2 mo) 110.5±3.2 334±11 42±2 20.5±0.4 329±6 8.5±0.2 28.6±2.1 2.35±0.22*
MI–vehicle (4 mo) 105.5±2.7 328±6* 42±2 19.7±0.5 343±7 8.0±0.1 30.4±1.5 2.24±0.13
MI–Ac-SDKP (prevention) 104.1±4.4 314±28 44±3 20.2±0.3 326±7 8.9±0.4§ 25.0±0.8 2.42±0.15
MI–Ac-SDKP (reversal) 113.9±3.1 331±7 45±3 19.6±0.3 312±11 7.9±0.2 31.8±1.3 2.25±0.16

SBP, indicates systolic blood pressure; HR, heart rate; IS, infarct size; LVW/BW, left ventricular weight/body weight; MCSA, myocyte cross-sectional area; LVDd, left ventricular diastolic dimension; EF, ejection fraction; E/A, ratio of E and A waves.

*

P<0.01 vs sham

P<0.001 vs sham

P=0.004 vs MI-vehicle (4 months)

§

P=0.057 vs MI-vehicle (4 months).

P=ns vs MI-vehicle (4 months)

P=ns vs MI-vehicle (2 months).